Latest News
News from the FDA/CDC
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025.
Letters from Maine
The Future of Obesity
Latest News
Reducing Unnecessary Antibiotics for Conjunctivitis
Study: Additional antibiotics or follow-up care was uncommon in pink eye, suggesting initial antibiotics may not be needed.
Latest News
Is Screen Time to Blame for Rising Rates of Myopia in Children?
High exposure to screen time with computers and television, but not smartphones, was significantly associated with myopia.
Child Psychiatry Consult
Climate Change, Climate Anxiety, Climate Hope
Between sensationalized news coverage, political controversy, and international disasters, it is no wonder some youth are overwhelmed by climate...
Latest News
FDA Proposes that Interchangeability Status for Biosimilars Doesn’t Need Switching Studies
The new draft guidance reflects updated scientific thinking on biosimilars, the agency said.
Commentary
How Well Do Clinicians Support Patients’ Sexual Health?
Sexuality needs to be addressed in addition to sexual health.
From the Journals
Which Surgeries Drive the Most Opioid Prescriptions in Youth?
Three procedures accounted for 59.1% of morphine milligram equivalents: Tonsillectomy and/or adenoidectomy, open treatment of upper extremity...
Conference Coverage
Neurofilament Light Chain Detects Early Chemotherapy-Related Neurotoxicity
“Nfl after a single cycle could detect axonal degeneration,” says the lead author of new research.
Conference Coverage
First-line Canakinumab Without Steroids Shows Effectiveness for Systemic Juvenile Idiopathic Arthritis
For JIA, a disease with limited options, a three-injection course of canakinumab was associated with durable control of disease in the absence of...
Latest News
CMS Announces End to Cyberattack Relief Program
Payments from the Accelerated and Advance Payment program will close for application in July.